Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1268153Generated: October 26, 2026

9H-Purin-2-amine, 6-chloro-9-[2-(2,2-dimethyl-1,3-dioxan-5-ylidene)ethyl]- → 6-Chloro-9-[2-(2,2-dimethyl-1,3-dioxan-5-yl)ethyl]-9H-purin-2-amine

https://huagongshe.com/reaction/1268153

Reaction equation

Participants

RoleNameHCIDCharge
Reactant9H-Purin-2-amine, 6-chloro-9-[2-(2,2-dimethyl-1,3-dioxan-5-ylidene)ethyl]-HCID 9861478—
CatalystPalladiumHCID 23938—
SolventTetrahydrofuranHCID 8028—
Product6-Chloro-9-[2-(2,2-dimethyl-1,3-dioxan-5-yl)ethyl]-9H-purin-2-amineHCID 1177134663.6%

Reaction Steps

5% Palladium on carbon (1.5 g) in tetrahydrofuran (40 ml) was prehydrogenated for 30 min at 50 p.s.i. 2,2-Dimethyl-5-[2-(2-amino-6-chloropurin-9-yl)]ethylidene-1,3-dioxane (3.0 g) in tetrahydrofuran (80 ml) was added and washed in with tetrahydrofuran (30 ml). The mixture was hydrogentated overnight at 50 p.s.i. with stirring. The catalyst was removed by filtration to give a colourless solution. The solvent was removed under reduced pressure and the residue recrystallised from IPA to give the title compound (1.92 g, 62.2% yield). Analysis: Found C: 49.98; H: 5.82; N: 22.42%; Required: C: 50.08; H: 5.82; N: 22.46%. 5-[2-(2-Amino-6-chloropurin-9-yl)ethyl]-2,2-dimethyl-1,3-dioxane can be converted to penciclovir using techniques known in the art such as those described in EP 141927.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS06555685B1
Source datasetuspto-grants-2003_04
ORD IDord-8de46968aa714828914c92a8962e6479
Source noteuspto-grants-2003_04